These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6499080)

  • 1. Antivertigo agents. III. Synthesis of 5,6,7,8-tetrahydro-1,6-naphthyridine methyl homologs.
    Shiozawa A; Ichikawa Y; Komuro C; Kurashige S; Miyazaki H; Yamanaka H; Sakamoto T
    Chem Pharm Bull (Tokyo); 1984 Jul; 32(7):2522-9. PubMed ID: 6499080
    [No Abstract]   [Full Text] [Related]  

  • 2. Antivertigo agents. V. Quantitative structure-activity relationships of 6-[2-(4-aryl-1-piperazinyl)ethyl]-5,6,7,8-tetrahydro-1,6-naphthyridine s.
    Shiozawa A; Kogo Y; Ichikawa Y; Komuro C; Ishikawa M; Kurashige S; Miyazaki H; Yamanaka H; Sakamoto T
    Chem Pharm Bull (Tokyo); 1985 Dec; 33(12):5332-40. PubMed ID: 3833382
    [No Abstract]   [Full Text] [Related]  

  • 3. Antivertigo agents. II. Structure-activity relationships of 6-substituted 5,6,7,8-tetrahydro-1,6-naphthyridines.
    Shiozawa A; Ichikawa Y; Ishikawa M; Kogo Y; Kurashige S; Miyazaki H; Yamanaka H; Sakamoto T
    Chem Pharm Bull (Tokyo); 1984 Mar; 32(3):995-1005. PubMed ID: 6744495
    [No Abstract]   [Full Text] [Related]  

  • 4. Antivertigo agents. IV. Synthesis and antivertigo activity of 6-[omega-(4-aryl-1-piperazinyl)alkyl]-5,6,7,8-tetrahydro-1,6-naphth yridines.
    Shiozawa A; Ichikawa Y; Komuro C; Ishikawa M; Furuta Y; Kurashige S; Miyazaki H; Yamanaka H; Sakamoto T
    Chem Pharm Bull (Tokyo); 1984 Oct; 32(10):3981-93. PubMed ID: 6529796
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on biologically active haloganenated compounds. III. Synthesis and antibacterial activity of 7-fluoromethyl-1,8-naphthyridine and quinoline derivatives.
    Tani J; Mushika Y; Yamaguchi T
    Chem Pharm Bull (Tokyo); 1982 Oct; 30(10):3517-29. PubMed ID: 7160009
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthesis of antimicrobial agents. VI. Studies on the synthesis of furo[3,2-b][1,8]naphthyridine derivatives.
    Hayakawa I; Suzuki N; Suzuki K; Tanaka Y
    Chem Pharm Bull (Tokyo); 1984 Dec; 32(12):4914-22. PubMed ID: 6534540
    [No Abstract]   [Full Text] [Related]  

  • 7. Pyridonecarboxylic acids as antibacterial agents. V. Synthesis of 1-vinyl-1,4-dihydro-4-oxo-1,8- and 1,6-naphthyridine-3-carboxylic acids.
    Mishio S; Hirose T; Minamida A; Matsumoto J; Minami S
    Chem Pharm Bull (Tokyo); 1985 Oct; 33(10):4402-8. PubMed ID: 4092268
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthesis of 1,8-naphthyridine derivatives. Potential antihypertensive agents. II.
    Da Settimo A; Ferrarini PL; Mori C; Primofiore G; Subissi A
    Farmaco Sci; 1986 Nov; 41(11):827-38. PubMed ID: 2879740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Syntheses of nitrogen-containing heterocyclic compounds. XLIV. Syntheses of 5-substituted 1,6-naphthyridine derivatives using the Reissert compound of 1,6-naphthyridine (author's transl)].
    Hamada Y; Shigemura K
    Yakugaku Zasshi; 1979 Dec; 99(12):1225-8. PubMed ID: 544763
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis and biological activities of 10-substituted benzo[b][1,5]naphthyridines.
    Sinha BK; Sato RI
    J Pharm Sci; 1978 Mar; 67(3):407-9. PubMed ID: 347048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimalarials. 8-chloro-4-(2'-n,n-dibutylamino-1'-hydroxyethyl)benzo[h]-1,6-naphthyridine.
    Roseman KA; Gould MM; Linfield WM; Edwards BE
    J Med Chem; 1970 Mar; 13(2):230-3. PubMed ID: 4392367
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthesis and local anesthetic activity of (E)- and (Z)-diethylaminoethyliminothers of 1,8-naphtyridine.
    Ferrarini PL; Mori C; Tellini N
    Farmaco; 1990 Mar; 45(3):385-9. PubMed ID: 2383350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on heterocyclic compounds. IX. Synthesis and antiallergic activity of furo[2,3-b] [1,8]naphthyridine-3,4(2H,9H)-diones and 4H-furo[2,3-d]pyrido [1,2-alpha]-pyrimidine-3,4(2H)-diones.
    Kuo SC; Tsai SY; Li HT; Wu CH; Ishii K; Nakamura H
    Chem Pharm Bull (Tokyo); 1988 Nov; 36(11):4403-7. PubMed ID: 3246007
    [No Abstract]   [Full Text] [Related]  

  • 14. [Synthesis and preliminary pharmacological screening of 2,4-disubstituted N,N-dialkyl-1,8-naphthyridine-3-carboxamides].
    Di Braccio M; Roma G; Balbi A; Sottofattori E; Carazzone M
    Farmaco; 1989 Sep; 44(9):865-81. PubMed ID: 2604838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of inhibition of platelet aggregation of 1,8-naphthyridine derivatives.
    Ferrarini P; Mori C; Criscuoli M
    Farmaco; 1989 Jun; 44(6):579-84. PubMed ID: 2553036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of antimicrobial agents. III. Synthesis and antimicrobial activities of thiazolo[5,4-b]naphthyridine derivatives.
    Suzuki N; Dohmori R
    Chem Pharm Bull (Tokyo); 1979 Feb; 27(2):410-8. PubMed ID: 445677
    [No Abstract]   [Full Text] [Related]  

  • 17. Library synthesis using 5,6,7,8-tetrahydro-1,6-naphthyridines as scaffolds.
    Zhou Y; Beeler AB; Cho S; Wang Y; Franzblau SG; Snyder JK
    J Comb Chem; 2008; 10(4):534-40. PubMed ID: 18517255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-peptide alpha v beta 3 antagonists. Part 7: 3-Substituted tetrahydro-naphthyridine derivatives.
    Wang J; Breslin MJ; Coleman PJ; Duggan ME; Hunt CA; Hutchinson JH; Leu CT; Rodan SB; Rodan GA; Duong LT; Hartman GD
    Bioorg Med Chem Lett; 2004 Feb; 14(4):1049-52. PubMed ID: 15013021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of new 6H-indolo[2,3-b] [1,8]naphthyridines and their specific inhibition of benzodiazepine receptor.
    Da Settimo A; Primofiore G; Ferrarini PL; Mori C; Martini C; Pennacchi E; Lucacchini A
    Farmaco Sci; 1986 Aug; 41(8):577-85. PubMed ID: 3017748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Synthesis and biological activity of 1,2,3-triazol-1,8-naphthyridines].
    Livi O; Ferrarini PL; Tonetti I
    Farmaco Sci; 1976 Nov; 31(11):797-808. PubMed ID: 1010031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.